Antra Ziedins-Gilbank

Antra Ziedins-Gilbank is a seasoned professional in the pharmaceutical industry with extensive experience in rare diseases and oncology. Currently serving as a Pediatric Rare Disease Account Manager at Alexion Pharmaceuticals, Inc., Antra is involved in the commercial launch of Koselugo™ for pediatric Neurofibromatosis Type 1. Antra has also held significant roles at Deciphera Pharmaceuticals and Sanofi Genzyme, focusing on promoting innovative therapies for rare cancers and blood disorders. Additionally, Antra has been President of the Healthcare Businesswomen’s Association Greater Rochester Chapter since May 2019. Antra's educational background includes a B.A. in Economics and Psychology from the University of Rochester and an M.S. in Instructional Design, Development, and Evaluation from Syracuse University.